These outcomes, along with a preceding report showing that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like actions in mice,2 aid the principle of focusing on ACKR3 as a singular solution to modulate the opioid system, which could open new therapeutic avenues for opioid-associated disorders. These outcomes propose that conolidine https://samirs480wrm9.blogs100.com/profile